Extract

The main objectives for this study is to see how safe Zibotentan is in patients with scleroderma and kidney damage and whether it has any effect on their kidney function

Inclusion criteria

• Renal complications of systemic sclerosis (scleroderma renal crisis and chronic kidney disease)

Links

• euctr
• ictrp